Advances in integrative nanomedicine for improving infectious disease treatment in public health

European Journal of Integrative Medicine

Volumn 5, Issue 2, 2013, Pages 126-140

  Bell, Iris R ^a,b,c   Schwartz, Gary E ^a,b   Boyer, Nancy N ^d   Koithan, Mary ^a,c   Brooks, Audrey J ^a,b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b The University of Arizona   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d Private Practice   (United States)

Author keywords

Adaptation; Antioxidants; Drug delivery systems; Herbal medicine; Homeopathy; Infectious disease treatment; Medicinal plants; Nanomedicine; Nanoparticles; Network medicine; Silica

Indexed keywords

CEDAR LEAF OIL; CURCUMIN; NANOPARTICLE; QUERCETIN; RESVERATROL; SILYMARIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME NURSING; ANTIGEN SPECIFICITY; ANTIVIRAL ACTIVITY; ARTICLE; BIOAVAILABILITY; CASSIA FISTULA; CYTOKINE RELEASE; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; EPIDEMIC; EQUISETUM; GASTROINTESTINAL ABSORPTION; GELSEMIUM; GINKGO BILOBA; HERB DRUG INTERACTION; HOMEOPATHY; HOST RESISTANCE; HUMAN; HYDRASTIS; HYPERICUM; IMMUNE RESPONSE; IMMUNOREACTIVITY; INFECTION; LEPTOSPIROSIS; MAGNOLIACEAE; MALARIA; MORBIDITY; NANOMEDICINE; NANOTECHNOLOGY; NONHUMAN; OCCUPATIONAL EXPOSURE; PH; POKEWEED; PRIORITY JOURNAL; PUBLIC HEALTH; ROSEMARY; UPPER RESPIRATORY TRACT INFECTION;

EID: 84877001504     PISSN: 18763820     EISSN: 18763839     Source Type: Journal    
DOI: 10.1016/j.eujim.2012.11.002     Document Type: Article

References (259)

1. Rakel D. Integrative medicine 2012, Saunders, Philadelphia, PA. 3rd ed.
2. Csermely P., Agoston V., Pongor S. The efficiency of multi-target drugs: the network approach might help drug design. Trends in Pharmacological Sciences 2005, 26:178-182.
3. Bell I.R., Koithan M., Pincus D. Research methodological implications of nonlinear dynamical systems models for whole systems of complementary and alternative medicine. Forschende Komplementarmedizin und Klassische Naturheilkunde 2012, 19:15-21.
4. Fønnebø V., Grimsgaard S., Walach H., Ritenbaugh C., Norheim A.J., MacPherson H., Lewith G., Launsø L., Koithan M., Falkenberg T., Boon H., Aickin M. Researching complementary and alternative treatments - the gatekeepers are not at home. BMC Medical Research Methodology 2007, 7:7.
5. Chikramane P.S., Suresh A.K., Bellare J.R., Kane S.G. Extreme homeopathic dilutions retain starting materials: a nanoparticulate perspective. Homeopathy 2010, 99:231-242.
6. Upadhyay R.P., Nayak C. Homeopathy emerging as nanomedicine. International Journal of High Dilution Research 2011, 10:299-310.
7. Bell I.R., Koithan M. A model for homeopathic remedy effects: low dose nanoparticles, allostatic cross-adaptation, and time-dependent sensitization in a complex adaptive system. BMC Complementary and Alternative Medicine 2012, 12(1):191.
8. Bell IR, Koithan M, Brooks AJ. Testing the nanoparticle-allostatic cross-adaptation-sensitization model for homeopathic remedy effects. Homeopathy 2013, in press.
9. Bell I.R., Schwartz G.E. Adaptive network nanomedicine: an integrated model for homeopathic medicine. Frontiers in Bioscience (Scholar Ed) 2013, 5(2):685-708.
10. Buzea C., Pacheco I.I., Robbie K. Nanomaterials and nanoparticles: sources and toxicity. Biointerphases 2007, 2:MR17-MR71.
11. Roduner E. Size matters: why nanomaterials are different. Chemical Society Reviews 2006, 35:583-592.
12. Armstead A.L., Li B. Nanomedicine as an emerging approach against intracellular pathogens. International Journal of Nanomedicine 2011, 6:3281-3293.
13. Devi V.K., Jain N., Valli K.S. Importance of novel drug delivery systems in herbal medicines. Pharmacognosy Reviews 2010, 4:27-31.
14. Huang S., Chang W.H. Advantages of nanotechnology-based Chinese herb drugs on biological activities. Current Drug Metabolism 2009, 10:905-913.
15. Jia L. Nanoparticle formulation increases oral bioavailability of poorly soluble drugs: approaches experimental evidences and theory. Current Nanoscience 2005, 1:237-243.
16. DeCastro C.L., Mitchell B.S. Nanoparticles from mechanical attrition. Synthesis, functionalization, and surface treatment of nanoparticles 2002, 1-15. American Scientific Publisher, Valencia, CA. M.I. Baraton (Ed.).
17. Merisko-Liversidge E., Liversidge G.G. Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology. Advanced Drug Delivery Reviews 2011, 63:427-440.
18. Caron V., Willart J.F., Lefort R., Derollez P., Danede F., Descamps M. Solid state amorphization kinetic of alpha lactose upon mechanical milling. Carbohydrate Research 2011, 346:2622-2628.
19. Verma S., Gokhale R., Burgess D.J. A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions. International Journal of Pharmaceutics 2009, 380:216-222.
20. Belton D.J., Deschaume O., Perry C.C. An overview of the fundamentals of the chemistry of silica with relevance to biosilicification and technological advances. FEBS Journal 2012, 279:1710-1720.
21. Gwinn M.R., Vallyathan V. Nanoparticles: health effects - pros and cons. Environmental Health Perspectives 2006, 114:1818-1825.
22. Seaton A., Tran L., Aitken R., Donaldson K. Nanoparticles, human health hazard and regulation. Journal of the Royal Society, Interface 2010, 7(Suppl. 1):S119-S129.
23. Cao G., Wang Y. Nanostructures and nanomaterials: synthesis, properties and applications 2011, World Scientific, New Jersey. 2nd ed.
24. Ambrogio M.W., Thomas C.R., Zhao Y.L., Zink J.I., Stoddart J.F. Mechanized silica nanoparticles: a new frontier in theranostic nanomedicine. Accounts of Chemical Research 2011, 44(10):903-913.
25. Singh N., Manshian B., Jenkins G.J., Griffiths S.M., Williams P.M., Maffeis T.G., et al. NanoGenotoxicology: the DNA damaging potential of engineered nanomaterials. Biomaterials 2009, 30:3891-3914.
26. Winnik FM, Maysinger D. Quantum dot cytotoxicity and ways to reduce it. Accounts of Chemical Research; epub July 9, 2012.
27. Napierska D., Thomassen L.C., Rabolli V., Lison D., Gonzalez L., Kirsch-Volders M., et al. Size-dependent cytotoxicity of monodisperse silica nanoparticles in human endothelial cells. Small 2009, 5:846-853.
28. Passagne I., Morille M., Rousset M., Pujalte I., L'Azou B. Implication of oxidative stress in size-dependent toxicity of silica nanoparticles in kidney cells. Toxicology 2012, 299:112-124.
29. Sayes C.M., Wahi R., Kurian P.A., Liu Y., West J.L., Ausman K.D., et al. Correlating nanoscale titania structure with toxicity: a cytotoxicity and inflammatory response study with human dermal fibroblasts and human lung epithelial cells. Toxicological Sciences 2006, 92:174-185.
30. Song M., Yuan S., Yin J., Wang X., Meng Z., Wang H., et al. Size-dependent toxicity of nano-C60 aggregates: more sensitive indication by apoptosis-related Bax translocation in cultured human cells. Environmental Science and Technology 2012, 46:3457-3464.
31. Shi Z., Huang X., Liu B., Tao H., Cai Y., Tang R. Biological response of osteosarcoma cells to size-controlled nanostructured hydroxyapatite. Journal of Biomaterials Applications 2010, 25:19-37.
32. Al-Sadoon M.K., Abdel-Maksoud M.A., Rabah D.M., Badr G. Induction of apoptosis and growth arrest in human breast carcinoma cells by a snake (Walterinnesia aegyptia) venom combined with silica nanoparticles: crosstalk between Bcl2 and caspase 3. Cellular Physiology and Biochemistry 2012, 30:653-665.
33. Lim K.J., Bisht S., Bar E.E., Maitra A., Eberhart C.G. A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors. Cancer Biology & Therapy 2011, 11:464-473.
34. Harhaji L., Isakovic A., Raicevic N., Markovic Z., Todorovic-Markovic B., Nikolic N., et al. Multiple mechanisms underlying the anticancer action of nanocrystalline fullerene. European Journal of Pharmacology 2007, 568:89-98.
35. Akhtar M.J., Ahamed M., Kumar S., Khan M.M., Ahmad J., Alrokayan S.A. Zinc oxide nanoparticles selectively induce apoptosis in human cancer cells through reactive oxygen species. International Journal of Nanomedicine 2012, 7:845-857.
36. Nair H.B., Sung B., Yadav V.R., Kannappan R., Chaturvedi M.M., Aggarwal B.B. Delivery of antiinflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancer. Biochemical Pharmacology 2010, 80:1833-1843.
37. Burnett M.E., Wang S.Q. Current sunscreen controversies: a critical review. Photodermatology, Photoimmunology and Photomedicine 2011, 27:58-67.
38. Chonpathompikunlert P., Fan C.H., Ozaki Y., Yoshitomi T., Yeh C.K., Nagasaki Y. Redox nanoparticle treatment protects against neurological deficit in focused ultrasound-induced intracerebral hemorrhage. Nanomedicine (London) 2012, 7(7):1029-1043.
39. Ghosh D., Choudhury S.T., Ghosh S., Mandal A.K., Sarkar S., Ghosh A., et al. Nanocapsulated curcumin: oral chemopreventive formulation against diethylnitrosamine induced hepatocellular carcinoma in rat. Chemico-Biological Interactions 2012, 195:206-214.
40. Miroliaee A.E., Esmaily H., Vaziri-Bami A., Baeeri M., Shahverdi A.R., Abdollahi M. Amelioration of experimental colitis by a novel nanoselenium-silymarin mixture. Toxicology Mechanisms and Methods 2011, 21:200-208.
41. Morganti P., Fabrizi G., Palombo P., Palombo M., Guarneri F., Cardillo A., et al. New chitin complexes and their anti-aging activity from inside out. Journal of Nutrition, Health and Aging 2012, 16:242-245.
42. Neves A.R., Lucio M., Lima J.L., Reis S. Resveratrol in medicinal chemistry: a critical review of its pharmacokinetics, drug-delivery, and membrane interactions. Current Medicinal Chemistry 2012, 19:1663-1681.
43. Keijzer C., Slutter B., van der Zee R., Jiskoot W., van Eden W., Broere F. PLGA, PLGA-TMC and TMC-TPP nanoparticles differentially modulate the outcome of nasal vaccination by inducing tolerance or enhancing humoral immunity. PLoS ONE 2011, 6:e26684.
44. 2 exhibits adverse effects at environmental relevant concentrations. Environmental Science and Technology 2011, 45:3725-3730.
45. Rao K.S., Ghorpade A., Labhasetwar V. Targeting anti-HIV drugs to the CNS. Expert Opinion on Drug Delivery 2009, 6:771-784.
46. McMillan J., Batrakova E., Gendelman H.E. Cell delivery of therapeutic nanoparticles. Progress in Molecular Biology and Translational Science 2011, 104:563-601.
47. Boyapalle S., Mohapatra S. Nanotechnology applications to HIV vaccines and microbicides. Journal of Global Infectious Diseases 2012, 4:62-68.
48. Ranjan A., Pothayee N., Seleem M.N., Boyle S.M., Kasimanickam R., Riffle J.S., et al. Nanomedicine for intracellular therapy. FEMS Microbiology Letters 2012, 332(1):1-9.
49. Tiuman T.S., Santos A.O., Ueda-Nakamura T., Filho B.P., Nakamura C.V. Recent advances in leishmaniasis treatment. International Journal of Infectious Diseases 2011, 15:e525-e532.
50. Nnamani P.O., Scoles G., Krol S. Preliminary characterization of N-trimethylchitosan as a nanocarrier for malaria vaccine. Journal of Vector Borne Diseases 2011, 48:224-230.
51. Santos-Magalhaes N.S., Mosqueira V.C. Nanotechnology applied to the treatment of malaria. Advanced Drug Delivery Reviews 2010, 62:560-575.
52. Gnanadesigan M., Anand M., Ravikumar S., Maruthupandy M., Vijayakumar V., Selvam S., et al. Biosynthesis of silver nanoparticles by using mangrove plant extract and their potential mosquito larvicidal property. Asian Pacific Journal of Tropical Medicine 2011, 4:799-803.
53. Debbage P. Targeted drugs and nanomedicine: present and future. Current Pharmaceutical Design 2009, 15:153-172.
54. Montagnier L., Aissa J., Ferris S., Montagnier J.-L., Lavallee C. Electromagnetic signals are produced by aqueous nanostructures derived from bacterial DNA sequences. Interdisciplinary Sciences Computational Life Sciences 2009, 1:81-90.
55. Dave S.R., Gao X. Monodisperse magnetic nanoparticles for biodetection, imaging, and drug delivery: a versatile and evolving technology. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 2009, 1:583-609.
56. Sandhu A., Handa H., Abe M. Synthesis and applications of magnetic nanoparticles for biorecognition and point of care medical diagnostics. Nanotechnology 2010, 21:442001.
57. Hossu M., Ma L., Chen W. Nonlinear enhancement of spontaneous biophoton emission of sweet potato by silver nanoparticles. Journal of Photochemistry and Photobiology B 2010, 99:44-48.
58. Ruan B., Jacobi M. Ultrasonication effects on thermal and rheological properties of carbon nanotube suspensions. Nanoscale Research Letters 2012, 7:127.
59. Yao P., Hughes S. Macroscopic entanglement and violation of Bell's inequalities between two spatially separated quantum dots in a planar photonic crystal system. Optics Express 2009, 17:11505-11514.
60. Bhakta G., Shrivastava A., Maitra A. Magnesium phosphate nanoparticles can be efficiently used in vitro and in vivo as non-viral vectors for targeted gene delivery. Journal of Biomedical Nanotechnology 2009, 5:106-114.
61. Bisht S., Bhakta G., Mitra S., Maitra A. pDNA loaded calcium phosphate nanoparticles: highly efficient non-viral vector for gene delivery. International Journal of Pharmaceutics 2005, 288:157-168.
62. Huang S., Chen J.C., Hsu C.W., Chang W.H. Effects of nano calcium carbonate and nano calcium citrate on toxicity in ICR mice and on bone mineral density in an ovariectomized mice model. Nanotechnology 2009, 20:375102.
63. Tavares Cardoso M.A., Talebi M., Soares P.A., Yurteri C.U., van Ommen J.R. Functionalization of lactose as a biological carrier for bovine serum albumin by electrospraying. International Journal of Pharmaceutics 2011, 414:1-5.
64. Bhattacharyya S.S., Paul S., Khuda-Bukhsh A.R. Encapsulated plant extract (Gelsemium sempervirens) poly (lactide-co-glycolide) nanoparticles enhance cellular uptake and increase bioactivity in vitro. Experimental Biology and Medicine (Maywood, NJ) 2010, 235:678-688.
65. Bhakta G., Mitra S., Maitra A. DNA encapsulated magnesium and manganous phosphate nanoparticles: potential non-viral vectors for gene delivery. Biomaterials 2005, 26:2157-2163.
66. Bhatti M., Yahioglu G., Milgrom L.R., Garcia-Maya M., Chester K.A., Deonarain M.P. Targeted photodynamic therapy with multiply-loaded recombinant antibody fragments. International Journal of Cancer 2008, 122:1155-1163.
67. Deonarain M.P., Milgrom L.R. A conjugation platform for the targeted delivery of anticancer agents. Innovations in Pharmaceutical Technology 2011, 56-59.
68. Jain A.K., Das M., Swarnakar N.K., Jain S. Engineered PLGA nanoparticles: an emerging delivery tool in cancer therapeutics. Critical Reviews in Therapeutic Drug Carrier Systems 2011, 28:1-45.
69. Hueber A.J., Stevenson R., Stokes R.J., Graham D., Garside P., McInnes I.B. Imaging inflammation in real time - future of nanoparticles. Autoimmunity 2009, 42:368-372.
70. Ahmad Z., Pandey R., Sharma S., Khuller G.K. Alginate nanoparticles as antituberculosis drug carriers: formulation development, pharmacokinetics and therapeutic potential. Indian Journal of Chest Diseases and Allied Sciences 2006, 48:171-176.
71. Bershteyn A., Hanson M.C., Crespo M.P., Moon J.J., Li A.V., Suh H., et al. Robust IgG responses to nanograms of antigen using a biomimetic lipid-coated particle vaccine. Journal of Controlled Release 2012, 157:354-365.
72. Diwan M., Elamanchili P., Cao M., Samuel J. Dose sparing of CpG oligodeoxynucleotide vaccine adjuvants by nanoparticle delivery. Current Drug Delivery 2004, 1:405-412.
73. Bhattacharyya S.S., Mandal S.K., Biswas R., Paul S., Pathak S., Boujedaini N., et al. In vitro studies demonstrate anticancer activity of an alkaloid of the plant Gelsemium sempervirens. Experimental Biology and Medicine (Maywood, NJ) 2008, 233:1591-1601.
74. Prakash D.J., Arulkumar S., Sabesan M. Effect of nanohypericum (Hypericum perforatum gold nanoparticles) treatment on restraint stress induced behavioral and biochemical alteration in male albino mice. Pharmacognosy Research 2010, 2:330-334.
75. Chifiriuc M.C., Grumezescu V., Grumezescu A.M., Saviuc C.M., Lazar V., Andronescu E. Hybrid magnetite nanoparticles/Rosmarinus officinalis essential oil nanobiosystem with antibiofilm activity. Nanoscale Research Letters 2012, 7:209.
76. He S., Zhou B., Zhang S., Lei Z., Zhang Z. Preparation of nanoparticles of Magnolia bark extract by rapid expansion from supercritical solution into aqueous solutions. Journal of Microencapsulation 2011, 28:183-189.
77. Han L., Fu Y., Cole A.J., Liu J., Wang J. Co-encapsulation and sustained-release of four components in ginkgo terpenes from injectable PELGE nanoparticles. Fitoterapia 2012, 83(4):721-731.
78. Felippi C.C., Oliveira D., Stroher A., Carvalho A.R., Van Etten E.A., Bruschi M., et al. Safety and efficacy of antioxidants-loaded nanoparticles for an anti-aging application. Journal of Biomedical Nanotechnology 2012, 8:316-321.
79. Lopes C.M., Martins-Lopes P., Souto E.B. Nanoparticulate carriers (NPC) for oral pharmaceutics and nutraceutics. Pharmazie 2010, 65:75-82.
80. Meng X., Zu Y., Zhao X., Li Q., Jiang S., Sang M. Characterization and pharmacokinetics of coenzyme Q10 nanoparticles prepared by a rapid expansion of supercritical solution process. Pharmazie 2012, 67:161-167.
81. Ghosh D., Ghosh S., Sarkar S., Ghosh A., Das N., Das Saha K., et al. Quercetin in vesicular delivery systems: evaluation in combating arsenic-induced acute liver toxicity associated gene expression in rat model. Chemico-Biological Interactions 2010, 186:61-71.
82. Anitha A, Maya S, Deepa N, Chennazhi KP, Nair SV, Jayakumar R. Curcumin-loaded N,O-carboxymethyl chitosan nanoparticles for cancer drug delivery. Journal of Biomaterials Science Polymer Edition; epub June 28, 2011.
83. Koufaki M., Detsi A., Kiziridi C. Multifunctional lipoic acid conjugates. Current Medicinal Chemistry 2009, 16:4728-4742.
84. da Silva E.R., Maquiaveli Cdo C., Magalhaes P.P. The leishmanicidal flavonols quercetin and quercitrin target Leishmania (Leishmania) amazonensis arginase. Experimental Parasitology 2012, 130:183-188.
85. Zandi K., Teoh B.T., Sam S.S., Wong P.F., Mustafa M.R., Abubakar S. Antiviral activity of four types of bioflavonoid against dengue virus type-2. Virology Journal 2011, 8:560.
86. Ganesan S., Faris A.N., Comstock A.T., Wang Q., Nanua S., Hershenson M.B., et al. Quercetin inhibits rhinovirus replication in vitro and in vivo. Antiviral Research 2012, 94(3):258-271.
87. Choi H.J., Song J.H., Kwon D.H. Quercetin 3-rhamnoside exerts antiinfluenza A virus activity in mice. Phytotherapy Research 2012, 26:462-464.
88. Li H., Zhao X., Ma Y., Zhai G., Li L., Lou H. Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. Journal of Controlled Release 2009, 133:238-244.
89. Cao X., Fu M., Wang L., Liu H., Deng W., Qu R., et al. Oral bioavailability of silymarin formulated as a novel 3-day delivery system based on porous silica nanoparticles. Acta Biomaterialia 2012, 8:2104-2112.
90. 4-induced hepatic injury and fibrosis through reduction of pro-inflammatory cytokines and stellate cell activation. Laboratory Investigation 2011, 91:1383-1395.
91. Agalya Priyadarshini K., Murugan K., Panneerselvam C., Ponarulselvam S., Hwang J.S., Nicoletti M. Biolarvicidal and pupicidal potential of silver nanoparticles synthesized using Euphorbia hirta against Anopheles stephensi Liston (Diptera: Culicidae). Parasitology Research 2012, 111(3):997-1006.
92. Sonkaew P., Sane A., Suppakul P. Antioxidant activities of curcumin and ascorbyl dipalmitate nanoparticles and their activities after incorporation into cellulose-based packaging films. Journal of Agricultural and Food Chemistry 2012, 60(21):5388-5399.
93. Antoniades C., Psarros C., Tousoulis D., Bakogiannis C., Shirodaria C., Stefanadis C. Nanoparticles: a promising therapeutic approach in atherosclerosis. Current Drug Delivery 2010, 7:303-311.
94. Lee J.E., Lee N., Kim T., Kim J., Hyeon T. Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications. Accounts of Chemical Research 2011, 44:893-902.
95. Pattekari P., Zheng Z., Zhang X., Levchenko T., Torchilin V., Lvov Y. Top-down and bottom-up approaches in production of aqueous nanocolloids of low solubility drug paclitaxel. Physical Chemistry Chemical Physics 2011, 13:9014-9019.
96. Singh S.K., Srinivasan K.K., Gowthamarajan K., Singare D.S., Prakash D., Gaikwad N.B. Investigation of preparation parameters of nanosuspension by top-down media milling to improve the dissolution of poorly water-soluble glyburide. European Journal of Pharmaceutics and Biopharmaceutics 2011, 78:441-446.
97. Cai Z., Wang Y., Zhu L.J., Liu Z.Q., Nanocarriers: a general strategy for enhancement of oral bioavailability of poorly absorbed or pre-systemically metabolized drugs. Current Drug Metabolism 2010, 11:197-207.
98. Wong H.L., Chattopadhyay N., Wu X.Y., Bendayan R. Nanotechnology applications for improved delivery of antiretroviral drugs to the brain. Advanced Drug Delivery Reviews 2010, 62:503-517.
99. Chadwick S., Kriegel C., Amiji M. Nanotechnology solutions for mucosal immunization. Advanced Drug Delivery Reviews 2010, 62:394-407.
100. Reis C.P., Damge C. Nanotechnology as a promising strategy for alternative routes of insulin delivery. Methods in Enzymology 2012, 508:271-294.
101. Fang I.J., Trewyn B.G. Application of mesoporous silica nanoparticles in intracellular delivery of molecules and proteins. Methods in Enzymology 2012, 508:41-59.
102. Uskokovic V., Uskokovic D.P. Nanosized hydroxyapatite and other calcium phosphates: chemistry of formation and application as drug and gene delivery agents. Journal of Biomedical Materials Research. Part B, Applied Biomaterials 2011, 96:152-191.
103. Asano H., Muraki S., Endo H., Bandow S., Iijima S. Strong magnetism observed in carbon nanoparticles produced by the laser vaporization of a carbon pellet in hydrogen-containing Ar balance gas. Journal of Physics: Condensed Matter 2010, 22:334209.
104. Ahmad Z., Khuller G.K. Alginate-based sustained release drug delivery systems for tuberculosis. Expert Opinion on Drug Delivery 2008, 5:1323-1334.
105. Al-Jamal W.T., Kostarelos K. Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine. Accounts of Chemical Research 2011, 44:1094-1104.
106. Hadrup N., Loeschner K., Mortensen A., Sharma A.K., Qvortrup K., Larsen E.H., et al. The similar neurotoxic effects of nanoparticulate and ionic silver in vivo and in vitro. Neurotoxicology 2012, 33:416-423.
107. Liu Y., Gao Y., Zhang L., Wang T., Wang J., Jiao F., et al. Potential health impact on mice after nasal instillation of nano-sized copper particles and their translocation in mice. Journal of Nanoscience and Nanotechnology 2009, 9:6335-6343.
108. Almeida J.P., Chen A.L., Foster A., Drezek R. In vivo biodistribution of nanoparticles. Nanomedicine (London) 2011, 6:815-835.
109. Nowrouzi A., Meghrazi K., Golmohammadi T., Golestani A., Ahmadian S., Shafiezadeh M., et al. Cytotoxicity of subtoxic AgNP in human hepatoma cell line (HepG2) after long-term exposure. Iranian Biomedical Journal 2010, 14:23-32.
110. Park E.J., Park K. Oxidative stress and pro-inflammatory responses induced by silica nanoparticles in vivo and in vitro. Toxicology Letters 2009, 184:18-25.
111. Liu T., Li L., Teng X., Huang X., Liu H., Chen D., et al. Single and repeated dose toxicity of mesoporous hollow silica nanoparticles in intravenously exposed mice. Biomaterials 2011, 32:1657-1668.
112. 2 nanoparticles exposure as an early indicator of cytotoxicity. Journal of Nanobiotechnology 2011, 9:29.
113. Seleem M.N., Munusamy P., Ranjan A., Alqublan H., Pickrell G., Sriranganathan N. Silica-antibiotic hybrid nanoparticles for targeting intracellular pathogens. Antimicrobial Agents and Chemotherapy 2009, 53:4270-4274.
114. Raffa V., Vittorio O., Riggio C., Cuschieri A. Progress in nanotechnology for healthcare. Minimally Invasive Therapy & Allied Technologies 2010, 19:127-135.
115. Ghosh S., Patil S., Ahire M., Kitture R., Gurav D.D., Jabgunde A.M., et al. Gnidia glauca flower extract mediated synthesis of gold nanoparticles and evaluation of its chemocatalytic potential. Journal of Nanobiotechnology 2012, 10:17.
116. Daisy P., Saipriya K. Biochemical analysis of Cassia fistula aqueous extract and phytochemically synthesized gold nanoparticles as hypoglycemic treatment for diabetes mellitus. International Journal of Nanomedicine 2012, 7:1189-1202.
117. Das S., Das J., Samadder A., Bhattacharyya S., Das D., Khuda-Bukhsh A.R. Biosynthesized silver nanoparticles by ethanolic extracts of Phytolacca decandra, Gelsemium sempervirens, Hydrastis canadensis and Thuja occidentalis induce differential cytotoxicity through G2/M arrest in A375 cells. Colloids and Surfaces B: Biointerfaces 2013, 101:325-336.
118. Philip D. Green synthesis of gold and silver nanoparticles using Hibiscus rosa sinensis. Physica E: Low-dimensional Systems and Nanostructures 2010, 42:1417-1424.
119. Nune S.K., Chanda N., Shukla R., Katti K., Kulkarni R.R., Thilakavathi S., et al. Green nanotechnology from tea: phytochemicals in tea as building blocks for production of biocompatible gold nanoparticles. Journal of Materials Chemistry 2009, 19:2912-2920.
120. Bhattacharyya S.S., Das J., Das S., Samadder A., Das D., De A., et al. Rapid green synthesis of silver nanoparticles from silver nitrate by a homeopathic mother tincture Phytolacca decandra. Zhong Xi Yi Jie He Xue Bao 2012, 10:546-554.
121. Bornhoft G., Matthiessen P.F. Homeopathy in healthcare - effectiveness, appropriateness, safety, costs 2011, Springer, Berlin, Germany.
122. Witt C., Albrecht H. New directions in homeopathy research 2009, KVC Verlag, Essen, Germany.
123. Witt C.M., Luedtke R., Baur R., Willich S.N. Homeopathic medical practice: long-term results of a cohort study with 3981 patients. BMC Public Health 2005, 5. 115.
124. Bronstein A.C., Spyker D.A., Cantilena L.R., Green J., Rumack B.H., Giffin S.L. 2008 annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 26th annual report. Clinical Toxicology (Philadelphia, Pa.) 2009, 47:911-1084.
125. Merisko-Liversidge E., Liversidge G.G., Cooper E.R. Nanosizing: a formulation approach for poorly-water-soluble compounds. European Journal of Pharmaceutical Sciences 2003, 18:113-120.
126. Hahnemann S. Organon of the medical art 1843, Birdcage Books, Redmond, WA. 6th ed.
127. Kayne S.B. Homeopathic practice 2008, Pharmaceutical Press, London.
128. Kim T.H., Kim M., Park H.S., Shin U.S., Gong M.S., Kim H.W. Size-dependent cellular toxicity of silver nanoparticles. Journal of Biomedical Materials Research. Part A 2012, 100(4):1033-1043.
129. Barik T.K., Sahu B., Swain V. Nanosilica-from medicine to pest control. Parasitology Research 2008, 103:253-258.
130. Wang T., Jiang H., Zhao Q., Wang S., Zou M., Cheng G. Enhanced mucosal and systemic immune responses obtained by porous silica nanoparticles used as an oral vaccine adjuvant: effect of silica architecture on immunological properties. International Journal of Pharmaceutics 2012, 436:351-358.
131. Boericke W. Pocket manual of homeopathic materia medica 1927, Boericke and Tafel, Inc., Santa Rosa, CA.
132. Rao M.L., Roy R., Bell I.R. The defining role of structure (including epitaxy) in the plausibility of homeopathy. Homeopathy 2007, 96:175-182.
133. Keck C.M., Muller R.H. Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. European Journal of Pharmaceutics and Biopharmaceutics 2006, 62:3-16.
134. Ives J.A., Moffett J.R., Arun P., Lam D., Todorov T.I., Brothers A.B., et al. Enzyme stabilization by glass-derived silicates in glass-exposed aqueous solutions. Homeopathy 2010, 99:15-24.
135. Demangeat J.L. NMR relaxation evidence for solute-induced nanosized superstructures in ultramolecular aqueous dilutions of silica-lactose. Journal of Molecular Liquids 2010, 155:71-79.
136. Milgrom L.R., King K.R., Lee J., Pinkus A.S. On the investigation of homeopathic potencies using low resolution NMR T2 relaxation times: an experimental and critical survey of the work of Roland Conte et al. British Homoeopathic Journal 2001, 90:5-13.
137. Liu L., Randolph T.W., Carpenter J.F. Particles shed from syringe filters and their effects on agitation-induced protein aggregation. Journal of Pharmaceutical Sciences 2012, 101:2952-2959.
138. Perry C.C., Keeling-Tucker T. Crystalline silica prepared at room temperature from aqueous solution in the presence of intrasilica bioextracts. Chemical Communications (Cambridge, England) 1998, 2587-2588.
139. Anick D.J., Ives J.A. The silica hypothesis for homeopathy: physical chemistry. Homeopathy 2007, 96:189-195.
140. Liu Y., Kathan K., Saad W., Prudhomme R.K. Ostwald ripening of B-carotene nanoparticles. Physical Review Letters 2007, 98:1-4.
141. Tang C., Zhou T., Yang J., Zhang Q., Chen F., Fu Q., et al. Wet-grinding assisted ultrasonic dispersion of pristine multi-walled carbon nanotubes (MWCNTs) in chitosan solution. Colloids and Surfaces. B, Biointerfaces 2011, 86:189-197.
142. Abbasi A.R., Morsali A. Influence of solvents on the morphological properties of AgBr nano-structures prepared using ultrasound irradiation. Ultrasonics Sonochemistry 2012, 19:540-545.
143. Perry C.C. An overview of silica in biology: its chemistry and recent technological advances. Progress in Molecular and Subcellular Biology 2009, 47:295-313.
144. Song L., Yang K., Jiang W., Du P., Xing B. Adsorption of bovine serum albumin on nano and bulk oxide particles in deionized water. Colloids and Surfaces. B, Biointerfaces 2012, 94:341-346.
145. Relaix S., Leheny R.L., Reven L., Sutton M. Memory effect in composites of liquid crystal and silica aerosil. Physical Review E: Statistical, Nonlinear, and Soft Matter Physics 2011, 84:061705.
146. Baca H.K., Carnes E.C., Ashley C.E., Lopez D.M., Douthit C., Karlin S., et al. Cell-directed-assembly: directing the formation of nano/bio interfaces and architectures with living cells. Biochimica et Biophysica Acta 2011, 1810:259-267.
147. Kaehr B., Townson J.L., Kalinich R.M., Awad Y.H., Swartzentruber B.S., Dunphy D.R., et al. Cellular complexity captured in durable silica biocomposites. Proceedings of the National Academy of Sciences of the United States of America 2012, 109(43):17336-17341.
148. Hornung V., Bauernfeind F., Halle A., Samstad E.O., Kono H., Rock K.L., et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nature Immunology 2008, 9:847-856.
149. Zhu M., Li Y., Shi J., Feng W., Nie G., Zhao Y. Exosomes as extrapulmonary signaling conveyors for nanoparticle-induced systemic immune activation. Small 2012, 8:404-412.
150. Zhu M., Tian X., Song X., Li Y., Tian Y., Zhao Y., et al. Nanoparticle-induced exosomes target antigen-presenting cells to initiate Th1-type immune activation. Small 2012, 8(18):2841-2848.
151. Ive E.C., Couchman I.M., Reddy L. Therapeutic effect of Arsenicum album on leukocytes. International Journal of Molecular Sciences 2012, 13:3979-3987.
152. Singare D.S., Marella S., Gowthamrajan K., Kulkarni G.T., Vooturi R., Rao P.S. Optimization of formulation and process variable of nanosuspension: an industrial perspective. International Journal of Pharmaceutics 2010, 402(1-2):213-220.
153. Elia V., Napoli E., Germano R. The 'memory of water': an almost deciphered enigma. Dissipative structures in extremely dilute aqueous solutions. Homeopathy 2007, 96:163-169.
154. Iavicoli I., Calabrese E.J., Nascarella M.A. Exposure to nanoparticles and hormesis. Dose Response 2010, 8:501-517.
155. Karpukhin A.V., Avkhacheva N.V., Yakovlev R.Y., Kulakova I.I., Yashin V.A., Lisichkin G.V., et al. Effect of detonation nanodiamonds on phagocyte activity. Cell Biology International 2011, 35:727-733.
156. Calabrese E.J. Converging concepts: adaptive response, preconditioning, and the Yerkes-Dodson Law are manifestations of hormesis. Ageing Research Reviews 2008, 7:8-20.
157. Calabrese E.J. Hormesis is central to toxicology, pharmacology and risk assessment. Human and Experimental Toxicology 2010, 29:249-261.
158. Calabrese E.J., Bachmann K.A., Bailer A.J., Bolger P.M., Borak J., Cai L., et al. Biological stress response terminology: integrating the concepts of adaptive response and preconditioning stress within a hormetic dose-response framework. Toxicology and Applied Pharmacology 2007, 222:122-128.
159. Mattson M.P. Hormesis defined. Ageing Research Reviews 2008, 7:1-7.
160. Van Wijk R., Wiegant F.A. Postconditioning hormesis and the homeopathic similia principle: molecular aspects. Human and Experimental Toxicology 2010, 29:561-565.
161. Van Wijk R., Wiegant F.A. Postconditioning hormesis and the similia principle. Frontiers in Bioscience (Elite Edition) 2011, 3:1128-1138.
162. Wiegant F.A., Prins H.A., Van Wijk R. Postconditioning hormesis put in perspective: an overview of experimental and clinical studies. Dose Response 2011, 9:209-224.
163. Calabrese V., Cornelius C., Cuzzocrea S., Iavicoli I., Rizzarelli E., Calabrese E.J. Hormesis, cellular stress response and vitagenes as critical determinants in aging and longevity. Molecular Aspects of Medicine 2011, 32:279-304.
164. Calabrese V., Cornelius C., Dinkova-Kostova A.T., Iavicoli I., Di Paola R., Koverech A., et al. Cellular stress responses, hormetic phytochemicals and vitagenes in aging and longevity. Biochimica et Biophysica Acta 2012, 1822:753-783.
165. Calabrese E.J. Paradigm lost, paradigm found: the re-emergence of hormesis as a fundamental dose response model in the toxicological sciences. Environmental Pollution 2005, 138:379-411.
166. Nascarella M.A., Calabrese E.J. A method to evaluate hormesis in nanoparticle dose-responses. Dose Response 2012, 10:344-354.
167. Demirovic D, Rattan SI. Establishing cellular stress response profiles as biomarkers of homeodynamics, health and hormesis. Experimental Gerontology; epub February 22, 2012.
168. Mihalik A., Csermely P. Heat shock partially dissociates the overlapping modules of the yeast protein-protein interaction network: a systems level model of adaptation. PLoS Computational Biology 2011, 7:e1002187.
169. Szalay M.S., Kovacs I.A., Korcsmaros T., Bode C., Csermely P. Stress-induced rearrangements of cellular networks: consequences for protection and drug design. FEBS Letters 2007, 581:3675-3680.
170. Vidal M., Cusick M.E., Barabasi A.L. Interactome networks and human disease. Cell 2011, 144:986-998.
171. Ives J.A., Jonas W.B., Frye J.C. Do serial dilutions really dilute?. Homeopathy 2010, 99:229-230.
172. Davidson J. Psychiatry and homeopathy. Basis for a dialogue. British Homoeopathic Journal 1994, 83:78-83.
173. Bell I.R., Howerter A., Jackson N., Brooks A.J., Schwartz G.E. Multi-week resting EEG cordance change patterns from repeated olfactory activation with two constitutionally-salient homeopathic remedies in healthy young adults. Journal of Alternative and Complementary Medicine 2012, 18:445-453.
174. Antelman S.M., Levine J., Gershon S. Time-dependent sensitization: the odyssey of a scientific heresy from the laboratory to the door of the clinic. Molecular Psychiatry 2000, 5:350-356.
175. Calabrese E.J., Jonas W.B. Homeopathy: clarifying its relationship to hormesis. Human and Experimental Toxicology 2010, 29(July (7)):531-536.
176. Calabrese E.J., Mattson M.P., Calabrese V. Resveratrol commonly displays hormesis: occurrence and biomedical significance. Human and Experimental Toxicology 2010, 29:980-1015.
177. Fisher P. What is homeopathy? An introduction. Frontiers in Bioscience (Elite Edition) 2012, 4:1669-1682.
178. Lira-Salazar G., Marines-Montiel E., Torres-Monzon J., Hernandez-Hernandez F., Salas-Benito J.S. Effects of homeopathic medications Eupatorium perfoliatum and Arsenicum album on parasitemia of Plasmodium berghei-infected mice. Homeopathy 2006, 95:223-228.
179. Pereira W.K., Lonardoni M.V., Grespan R., Caparroz-Assef S.M., Cuman R.K., Bersani-Amado C.A. Immunomodulatory effect of Canova medication on experimental Leishmania amazonensis infection. Journal of Infection 2005, 51:157-164.
180. Basu M.K., Lala S. Macrophage specific drug delivery in experimental leishmaniasis. Current Molecular Medicine 2004, 4:681-689.
181. Danesh-Bahreini M.A., Shokri J., Samiei A., Kamali-Sarvestani E., Barzegar-Jalali M., Mohammadi-Samani S. Nanovaccine for leishmaniasis: preparation of chitosan nanoparticles containing Leishmania superoxide dismutase and evaluation of its immunogenicity in BALB/c mice. International Journal of Nanomedicine 2011, 6:835-842.
182. Tafaghodi M., Khamesipour A., Jaafari M.R. Immunization against leishmaniasis by PLGA nanospheres encapsulated with autoclaved Leishmania major (ALM) and CpG-ODN. Parasitology Research 2011, 108:1265-1273.
183. Glatthaar-Saalmuller B. In vitro evaluation of the antiviral effects of the homeopathic preparation Gripp-Heel on selected respiratory viruses. Canadian Journal of Physiology and Pharmacology 2007, 85:1084-1090.
184. Ullman D. Controlled clinical trials evaluating the homeopathic treatment of people with human immunodeficiency virus or acquired immune deficiency syndrome. Journal of Alternative and Complementary Medicine 2003, 9:133-141.
185. Sherr J. Dynamic provings 1997, vol. 1. Dynamis Books, Malvern, Worcester, UK.
186. Lam R., Chen M., Pierstorff E., Huang H., Osawa E., Ho D. Nanodiamond-embedded microfilm devices for localized chemotherapeutic elution. ACS Nano 2008, 2:2095-2102.
187. Mochalin V.N., Shenderova O., Ho D., Gogotsi Y. The properties and applications of nanodiamonds. Nature Nanotechnology 2012, 7:11-23.
188. Bracho G., Varela E., Fernandez R., Ordaz B., Marzoa N., Menendez J., et al. Large-scale application of highly-diluted bacteria for Leptospirosis epidemic control. Homeopathy 2010, 99:156-166.
189. Ulery B.D., Kumar D., Ramer-Tait A.E., Metzger D.W., Wannemuehler M.J., Narasimhan B. Design of a protective single-dose intranasal nanoparticle-based vaccine platform for respiratory infectious diseases. PLoS ONE 2011, 6:e17642.
190. Tang M., Zhang T., Xue Y., Wang S., Huang M., Yang Y., et al. Dose dependent in vivo metabolic characteristics of titanium dioxide nanoparticles. Journal of Nanoscience and Nanotechnology 2010, 10:8575-8583.
191. Ferley J.P., Zmirou D., D'Adhemar D., Balducci F. A controlled evaluation of a homoeopathic preparation in the treatment of influenza-like syndromes. British Journal of Clinical Pharmacology 1989, 27:329-335.
192. Papp R., et al. Oscillococcinum in patients with influenza-like syndromes: a placebo-controlled double blind evaluation. British Homoeopathic Journal 1998, 87:69-76.
193. Vickers A.J., Smith C. Homoeopathic Oscillococcinum for preventing and treating influenza and influenza-like syndromes. Cochrane Database of Systematic Reviews 2006, 19:CD001957.
194. Haidvogl M., Riley D.S., Heger M., Brien S., Jong M., Fischer M., Lewith G.T., Jansen G., Thurneysen A.E. Homeopathic and conventional treatment for acute respiratory and ear complaints: a comparative study on outcome in the primary care setting. BMC Complementary and Alternative Medicine 2007, 2:7.
195. Trichard M., Chaufferin G., Nicoloyannis N. Pharmacoeconomic comparison between homeopathic and antibiotic treatment strategies in recurrent acute rhinopharyngitis in children. Homeopathy Journal of the Faculty of Homeopathy 2005, 94:3-9.
196. Friese K.H., Kruse S., Ludtke R., Moeller H. The homoeopathic treatment of otitis media in children - comparisons with conventional therapy. International Journal of Clinical Pharmacology and Therapeutics 1997, 35:296-301.
197. Sinha M.N., Siddiqui V.A., Nayak C., Singh V., Dixit R., Dewan D., et al. Randomized controlled pilot study to compare homeopathy and conventional therapy in acute otitis media. Homeopathy 2012, 101:5-12.
198. Bellavite P., Marzotto M., Chirumbolo S., Conforti A. Advances in homeopathy and immunology: a review of clinical research. Frontiers in Bioscience (Scholar Edition) 2011, 3:1363-1389.
199. Ramchandani N.M. Homoeopathic treatment of upper respiratory tract infections in children: evaluation of thirty case series. Complementary Therapies in Clinical Practice 2010, 16:101-108.
200. Schmiedel V., Klein P. A complex homeopathic preparation for the symptomatic treatment of upper respiratory infections associated with the common cold: an observational study. Explore (NY) 2006, 2:109-114.
201. Ramachandran C., Nair P.K., Clement R.T., Melnick S.J. Investigation of cytokine expression in human leukocyte cultures with two immune-modulatory homeopathic preparations. Journal of Alternative and Complementary Medicine 2007, 13:403-407.
202. Roeska K., Seilheimer B. Antiviral activity of Engystol(R) and Gripp-Heel(R): an in-vitro assessment. Journal of Immune Based Therapies and Vaccines 2010, 8:6.
203. Aickin M. The end of biomedical journals: there is madness in their methods. Journal of Alternative & Complementary Medicine 2005, 11:755-757.
204. Fisher P., Berman B., Davidson J., Reilly D., Thompson T. Are the clinical effects of homoeopathy placebo effects?. Lancet 2005, 366:2082-2083.
205. Ludtke R., Rutten A.L. The conclusions on the effectiveness of homeopathy highly depend on the set of analyzed trials. Journal of Clinical Epidemiology 2008, 61:1197-1204.
206. Shang A., Huwiler-Muntener K., Nartey L., Juni P., Dorig S., Sterne J.A., Pewsner D., Egger M. Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy. Lancet 2005, 366:726-732.
207. Adair B.M. Nanoparticle vaccines against respiratory viruses. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 2009, 1:405-414.
208. Papp I., Sieben C., Ludwig K., Roskamp M., Bottcher C., Schlecht S., et al. Inhibition of influenza virus infection by multivalent sialic-acid-functionalized gold nanoparticles. Small 2010, 6:2900-2906.
209. Tai W., Roberts L., Seryshev A., Gubatan J.M., Bland C.S., Zabriskie R., et al. Multistrain influenza protection induced by a nanoparticulate mucosal immunotherapeutic. Mucosal Immunology 2011, 4:197-207.
210. Calabrese E.J., Mattson M.P. Hormesis provides a generalized quantitative estimate of biological plasticity. Journal Of Cell Communication And Signaling 2011, 5:25-38.
211. Vithoulkas G. The science of homeopathy 1980, Grove Weidenfeld, NY.
212. Antelman S.M., Caggiula A.R., Kocan D., Knopf S., Meyer D., Edwards D.J., et al. One experience with 'lower' or 'higher' intensity stressors, respectively enhances or diminishes responsiveness to haloperidol weeks later: implications for understanding drug variability. Brain Research 1991, 566:276-283.
213. Sorg B., Bailie T., Tschirgi M., Li N., Wu W. Exposure to repeated low-level formaldehyde in rats increases basal corticosterone levels and enhances the corticosterone response to subsequent formaldehyde. Brain Research 2001, 898:314-320.
214. Csermely P. Chaperone overload is a possible contributor to 'civilization diseases'. Trends in Genetics 2001, 17:701-704.
215. Csermely P., Korcsmaros T., Kovacs I.A., Szalay M.S., Soti C. Systems biology of molecular chaperone networks. Novartis Foundation Symposium 2008, 291:45-54. discussion-8, 137-40.
216. Karatsoreos I.N., McEwen B.S. Psychobiological allostasis: resistance, resilience and vulnerability. Trends in Cognitive Sciences 2011, 15:576-584.
217. McEwen B.S. Protective and damaging effects of stress mediators: central role of the brain. Dialogues in Clinical Neuroscience 2006, 8:367-381.
218. Li C., Li X., Suzuki A.K., Fujitani Y., Jigami J., Nagaoka K., et al. Effects of exposure to nanoparticle-rich diesel exhaust on adrenocortical function in adult male mice. Toxicology Letters 2012, 209:277-281.
219. Rattan S.I., Deva T. Testing the hormetic nature of homeopathic interventions through stress response pathways. Human and Experimental Toxicology 2010, 29:551-554.
220. Wiegant F.A., Spieker N., van Wijk R. Stressor-specific enhancement of hsp induction by low doses of stressors in conditions of self- and cross-sensitization. Toxicology 1998, 127:107-119.
221. Coelho Moreira C.O., de Fatima Ferreira Borges da Costa J., Leal M.F., Ferreira de Andrade E., Rezende A.P., Imbeloni A.A., et al. Lymphocyte proliferation stimulated by activated Cebus apella macrophages treated with a complex homeopathic immune response modifiers. Homeopathy 2012, 101:74-79.
222. Naser B., Bodinet C., Tegtmeier M., Lindequist U. Thuja occidentalis (Arbor vitae): a review of its pharmaceutical. pharmacological and clinical properties. Evidence-Based Complementary and Alternative Medicine 2005, 2:69-78.
223. Bellavite P., Ortolani R., Pontarollo F., Pitari G., Conforti A. Immunology and homeopathy. 5. The rationale of the 'simile'. Evidence-Based Complementary and Alternative Medicine 2007, 4:149-163.
224. Bell I.R., Caspi O., Schwartz G.E., Grant K.L., Gaudet T.W., Rychener D., et al. Integrative medicine and systemic outcomes research: issues in the emergence of a new model for primary health care. Annals of Internal Medicine 2002, 162:133-140.
225. Koithan M., Bell I.R., Niemeyer K., Pincus D. A complex systems science perspective for whole systems of CAM research. Forschende Komplementarmedizin und Klassische Naturheilkunde 2012, 19:7-14.
226. Barabasi A.L., Gulbahce N., Loscalzo J. Network medicine: a network-based approach to human disease. Nature Reviews Genetics 2011, 12:56-68.
227. Brumovsky P.R., Gebhart G.F. Visceral organ cross-sensitization - an integrated perspective. Autonomic Neuroscience 2010, 153:106-115.
228. Calabrese V., Cornelius C., Trovato A., Cavallaro M., Mancuso C., Di Rienzo L., et al. The hormetic role of dietary antioxidants in free radical-related diseases. Current Pharmaceutical Design 2010, 16:877-883.
229. Vaiserman A.M. Hormesis and epigenetics: is there a link?. Ageing Research Reviews 2011, 10:413-421.
230. Danese A., McEwen B.S. Adverse childhood experiences, allostasis, allostatic load, and age-related disease. Physiology and Behavior 2012, 106:29-39.
231. Pincus D., Metten A. Nonlinear dynamics in biopsychosocial resilience. Nonlinear Dynamics, Psychology, and Life Sciences 2010, 14:353-380.
232. McEwen B.S. Central effects of stress hormones in health and disease: understanding the protective and damaging effects of stress and stress mediators. European Journal of Pharmacology 2008, 583:174-185.
233. Gross T., Blasius B. Adaptive coevolutionary networks: a review. Journal of the Royal Society, Interface 2008, 5:259-271.
234. Vasquez A., Dobrin R., Sergi D., Eckmann J.P., Oltvai Z.N., Barabasi A.L. The topological relationship between the large-scale attributes and local interaction patterns of complex networks. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:17940-17945.
235. Calabrese V., Cornelius C., Mancuso C., Pennisi G., Calafato S., Bellia F., et al. Cellular stress response: a novel target for chemoprevention and nutritional neuroprotection in aging, neurodegenerative disorders and longevity. Neurochemical Research 2008, 33:2444-2471.
236. Mattson M.P., Son T.G., Camandola S. Viewpoint: mechanisms of action and therapeutic potential of neurohormetic phytochemicals. Dose Response. 2007, 5:174-186.
237. Veeraapandian S., Sawant S.N., Doble M. Antibacterial and antioxidant activity of protein capped silver and gold nanoparticles synthesized with Escherichia coli. Journal of Biomedical Nanotechnology 2012, 8:140-148.
238. Kaul G., Thippeswamy H. Role of heat shock proteins in diseases and their therapeutic potential. Indian Journal of Microbiology 2011, 51:124-131.
239. Petrilli V., Dostert C., Muruve D.A., Tschopp J. The inflammasome: a danger sensing complex triggering innate immunity. Current Opinion in Immunology 2007, 19:615-622.
240. 2 nanoparticles in murine dendritic cells. Nanotoxicology 2011, 5:326-340.
241. Demento S.L., Eisenbarth S.C., Foellmer H.G., Platt C., Caplan M.J., Mark Saltzman W., et al. Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy. Vaccine 2009, 27:3013-3021.
242. Muruve D.A., Petrilli V., Zaiss A.K., White L.R., Clark S.A., Ross P.J., et al. The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 2008, 452:103-107.
243. Petrilli V., Martinon F. The inflammasome, autoinflammatory diseases, and gout. Joint, Bone, Spine 2007, 74:571-576.
244. Elenkov I.J., Iezzoni D.G., Daly A., Harris A.G., Chrousos G.P. Cytokine dysregulation, inflammation and well-being. Neuroimmunomodulation 2005, 12:255-269.
245. Stern S., Dror T., Stolovicki E., Brenner N., Braun E. Genome-wide transcriptional plasticity underlies cellular adaptation to novel challenge. Molecular Systems Biology 2007, 3:106.
246. Hale H.B. Cross-adaptation. Environmental Research 1969, 2:423-434.
247. Launay J.C., Besnard Y., Guinet-Lebreton A., Savourey G. Acclimation to intermittent hypobaric hypoxia modifies responses to cold at sea level. Aviation, Space, and Environmental Medicine 2006, 77:1230-1235.
248. Avena N.M., Rada P., Hoebel B.G. Evidence for sugar addiction: behavioral and neurochemical effects of intermittent, excessive sugar intake. Neuroscience and Biobehavioral Reviews 2008, 32:20-39.
249. Antelman S.M., Caggiula A.R. Oscillation follows drug sensitization: implications. Critical Reviews in Neurobiology 1996, 10:101-117.
250. Sorg B.A., Swindell S., Tschirgi M.L. Repeated low level formaldehyde exposure produces enhanced fear conditioning to odor in male, but not female, rats. Brain Research 2004, 1:11-19.
251. Sorg B., Tschirgi M., Swindell S., Chen L., Fang J. Repeated formaldehyde effects in an animal model for multiple chemical sensitivity. Annals of the New York Academy of Sciences 2001, 933:57-67.
252. Bharali D.J., Mousa S.A., Thanavala Y. Micro- and nanoparticle-based vaccines for hepatitis B. Advances in Experimental Medicine and Biology 2007, 601:415-421.
253. Camacho A.I., de Souza J., Sanchez-Gomez S., Pardo-Ros M., Irache J.M., Gamazo C. Mucosal immunization with Shigella flexneri outer membrane vesicles induced protection in mice. Vaccine 2011, 29:8222-8229.
254. Duceppe N., Tabrizian M. Advances in using chitosan-based nanoparticles for in vitro and in vivo drug and gene delivery. Expert Opinion on Drug Delivery 2010, 7:1191-1207.
255. Mansour H.M., Rhee Y.S., Wu X. Nanomedicine in pulmonary delivery. International Journal of Nanomedicine 2009, 4:299-319.
256. Laroui H., Sitaraman S.V., Merlin D. Gastrointestinal delivery of anti-inflammatory nanoparticles. Methods in Enzymology 2012, 509:101-125.
257. Bansal S.S., Goel M., Aqil F., Vadhanam M.V., Gupta R.C. Advanced drug delivery systems of curcumin for cancer chemoprevention. Cancer Prevention Research (Philadelphia) 2011, 4:1158-1171.
258. Beg S., Javed S., Kohli K. Bioavailability enhancement of coenzyme Q10: an extensive review of patents. Recent Patents on Drug Delivery Formulation 2010, 4:245-255.
259. Chikramane P.S., Kalita D., Suresh A.K., Kane S.G., Bellare J.R. Why extreme dilutions reach non-zero asymptotes: a nanoparticulate hypothesis based on froth flotation. Langmuir 2012, 28(45):15864-15875.